In-vivosignatures of neurodegeneration in isolated rapid eye movement sleep behaviour disorder
- 1 July 2020
- journal article
- research article
- Published by Wiley in European Journal of Neurology
- Vol. 27 (7), 1285-1295
- https://doi.org/10.1111/ene.14215
Abstract
Background and purpose Isolated rapid eye movement sleep behaviour disorder (iRBD) is a parasomnia, recently recognized as a risk factor for progression to Parkinson's disease, dementia with Lewy body and multiple system atrophy. Biomarker studies in iRBD are relevant due to lack of evidence in this condition. The identification of biomarkers able to predict progression to synucleinopathy diseases is critical for iRBD. Fluorodeoxyglucose-positron emission tomography (FDG-PET) imaging might provide information about ongoing neurodegenerative processes. In the present study, we tested for presence of brain hypometabolism patterns as biomarkers of neurodegeneration in single iRBD individuals. Methods We recruited 37 subjects with polysomnography-confirmed iRBD, with neuropsychological assessment and available FDG-PET scan. Images were analysed with a validated statistical parametric mapping procedure, providing individual hypometabolism maps. Results According to the neuropsychological evaluation, 22 subjects with iRBD had normal cognition and 15 subjects showed impairments, particularly in visuoperceptive/visuospatial and memory domains. One-fifth of the cases were impaired on the Qualitative Scoring of Pentagon Test. In 32 iRBD cases, FDG-PET statistical parametric maps revealed significant cerebral hypometabolism, namely in the occipital lobes (n = 5), occipital and cerebellar regions (n = 13), occipitoparietal regions (n = 13) and a selective cerebellar hypometabolism (n = 1). Five cases had normal FDG-PET scans. Conclusions These imaging findings indicate that brain neurodegenerative processes are present and already detectable in iRBD. The different hypometabolism patterns in the single individuals may reflect specific early pathophysiological events due to the underlying synucleinopathy, with a specific neural vulnerability for the occipital cortex that might pre-date a risk of progression towards dementia with Lewy body.This publication has 31 references indexed in Scilit:
- Cerebral glucose metabolism in idiopathic REM sleep behavior disorder is different from tau-related and α-synuclein-related neurodegenerative disorders: A brain [18F]FDG PET studyParkinsonism & Related Disorders, 2019
- The Metabolic Pattern of Idiopathic REM Sleep Behavior Disorder Reflects Early-Stage Parkinson DiseaseJournal of Nuclear Medicine, 2018
- Idiopathic REM sleep behaviour disorder and neurodegeneration — an updateNature Reviews Neurology, 2017
- The emerging role of PET imaging in dementiaF1000Research, 2017
- New Clinical Subtypes of Parkinson Disease and Their Longitudinal ProgressionJAMA Neurology, 2015
- Assessing Cerebral Glucose Metabolism in Patients with Idiopathic Rapid Eye Movement Sleep Behavior DisorderJournal of Cerebral Blood Flow & Metabolism, 2015
- Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical settingNeuroImage: Clinical, 2014
- Consistent abnormalities in metabolic network activity in idiopathic rapid eye movement sleep behaviour disorderBrain, 2014
- FDG-PET and amyloid-PET imaging: the diverging pathsCurrent Opinion in Neurology, 2014
- A Standardized [18F]-FDG-PET Template for Spatial Normalization in Statistical Parametric Mapping of DementiaNeuroinformatics, 2014